Takeda's Alogliptin Among MHLW Approval Recommendations; Pfizer, Alexion Also Gain
This article was originally published in PharmAsia News
Executive Summary
Japan's First Committee on New Drugs at the Ministry of Health, Labor and Welfare recommended for approval three Takeda drugs: alogliptin and pioglitazone/metformin combination - both for type 2 diabetes - and combination drug candesartan/amlodipine for hypertension